Search results
Johnson & Johnson (NYSE:JNJ) Stock Holdings Decreased by Mitchell Mcleod Pugh & Williams Inc.
ETF DAILY NEWS· 4 days agoMitchell Mcleod Pugh & Williams Inc. decreased its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 28,869 ...
13 Times Met Gala Attendees Took "Beauty Is Pain" Way Too Seriously And Wore Looks That Physically...
BuzzFeed via Yahoo News· 4 days agoFor Kim Kardashian, wearing her famous Mugler "wet look" dress was one of the most painful...
Consolidated Planning Corp Sells 1,063 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoConsolidated Planning Corp lessened its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 29,072 shares of ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 4 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 5 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
How a Florida man overcame a broken femur, fractured pelvis and now heart disease
Tampa Bay Times· 6 days agoLast month, 50 years of bike riding, running and pretending I’m Arnold Schwarzenegger in the gym failed me. With three grandparents dying of heart disease, I knew all along I was doomed. Late ...
Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)
ETF DAILY NEWS· 24 hours agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...
Amgen (NASDAQ:AMGN) Shares Down 2.7% on Insider Selling
ETF DAILY NEWS· 1 day agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) shares were down 2.7% on Monday after an insider sold shares in the company. The company traded as low as $301.09 and last traded at $302.91. Specifically ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort...
Benzinga· 4 days agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 6 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.